Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Mar 23, 2022 12:56pm
87 Views
Post# 34538234

RE:Newspromises from 2020 , gearing up says CEO Guy Chamberpot

RE:Newspromises from 2020 , gearing up says CEO Guy Chamberpot https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/tetra-plans-product-launch-confirms-offering/

Where is the money/ revenue  from these Din numbers that were issued in 2020 , has it gone into the private sub companies Guy set up. 
Is Reduvo Din profit going to go to Panag Pharma , Guy uses Tetra just to fund all  these sub private  companies and pay for research which he pays other companies to do, he does no research ! He is a general contractor just moving money and he will be fine no matter what happens to Tetra , where are the updates from Health Canada CEO ?  His private numbered company pulls in over 722,000.00 us  a year , he pumped and fooled us all. He has contracts we shareholders paid for that may never be used  without any approved product. He just likes to shop , run around and stay busy then we get news that he is talking with this company or that company to distribute product he does not and may never have .What a total waste of shareholders money, make a product first , seems like alot of cart before the horse mentality.So frustrating for shareholders to watch paying someone 500,000 a year to waste our money ! and move it into private INC. companies never to be seen again. 
<< Previous
Bullboard Posts
Next >>